Grant awarded

P3SysBioLab’s grant titled “Sphingolipid-Based Stratification and Therapeutic Targeting in Acute Myeloid Leukemia” has been selected as an awardee for American Cancer Society Institutional Research Grant (ACS-IRG) FY2025 ($50,000). We will develeop surface marker panels for sphingolipid-based subtyping in AML, and identify therapeutic vulnerabilities within sphingolipid metabolic pathway.